Trends in mortality and loss to follow-up in HIV care at the Nkongsamba Regional hospital, Cameroon

BMC Research Notes

Volumn 6, Issue 1, 2013, Pages

  Bekolo, Cavin Epie ^a   Webster, Jayne ^b   Batenganya, Moses ^c   Sume, Gerald Etapelong ^d   Kollo, Basile ^e  

^a Centre Médical d'Arrondissement de Baré   (Cameroon)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c UNIVERSITY OF WASHINGTON   (United States)

^d World Health Organisation (WHO)   (Cameroon)

^e UNIVERSITY OF DOUALA   (Cameroon)

Author keywords

Cameroon; HIV care; Loss to follow up; Mortality

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS;

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADOLESCENT; ADULT; ARTICLE; CAMEROON; CD4 LYMPHOCYTE COUNT; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MORTALITY; OUTPATIENT DEPARTMENT; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICS; SURVIVAL;

ADOLESCENT; ADULT; AMBULATORY CARE FACILITIES; ANTI-HIV AGENTS; CAMEROON; CD4 LYMPHOCYTE COUNT; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; MALE; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 84897604513     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-6-512     Document Type: Article

References (28)

1. Joint United Nations Programme on HIV/AIDS (UNAIDS), Global report: UNAIDS report on the global AIDS epidemic 2013 Geneva 2013
2. Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. Lawn SD, Harries AD, Anglaret X, Myer L, Wood R, AIDS 2008 22 Suppl 15 1897 908 18784453
3. Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa, 2007-2009: systematic review. Fox MP, Rosen S, TM IH 2010 15 Suppl 1 1 15
4. Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries. Brinkhof MW, Dabis F, Myer L, Bangsberg DR, Boulle A, Nash D, Bull World Health Organ 2008 86 Suppl 7 559 67 18670668
5. Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis. Brinkhof MW, Pujades-Rodriguez M, Egger M, PLoS One 2009 4 Suppl 6 5790 19495419
6. Central Bureau of the Census and Population Studies, La population du Cameroun en 2010 Yaounde 2010
7. National Institute of Statistics, Enquête Démographique et de Santé et à Indicateurs Multiples EDS-MICS 2011 Rapport Préliminaire sur la prévalence du VIH Yaounde 2011
8. Ministere de la Sante Publique du Cameroun, Rapport annuel des activités de lutte contre le VIH et les IST au Cameroun Yaounde 2011
9. Early warning indicators for HIV drug resistance in Cameroon during the year 2010. Billong SC, Fokam J, Nkwescheu AS, Kembou E, Milenge P, Tsomo Z, PLoS One 2012 7 Suppl 5 36777 22615810
10. Characterization of drug resistance mutations in naive and ART-treated patients infected with HIV-1 in Yaounde. Ceccarelli L, Salpini R, Moudourou S, Cento V, Santoro MM, Fokam J, Cameroon J Med Virol 2012 84 Suppl 5 721 7
11. Antiretroviral therapy in public and private routine health care clinics in Cameroon: lessons from the Douala antiretroviral (DARVIR) initiative. Laurent C, Meilo H, Guiard-Schmid JB, Mapoure Y, Noel JM, M'Bangue M, Clin infect dis off publ Infect Dis Soc Am 2005 41 Suppl 1 108 11
12. Antiretroviral treatment adherence and its determinants in Sub-Saharan Africa: a prospective study at Yaounde Central Hospital. Rougemont M, Stoll BE, Elia N, Ngang P, Cameroon AIDS Re Ther 2009 6 21 10.1186/1742-6405-6-21
13. Determinants of retention in care in an antiretroviral therapy (ART) program in urban Cameroon, 2003-2005. Tsague L, Koulla SS, Kenfak A, Kouanfack C, Tejiokem M, Abong T, Pan Afric Med J 2008 1 2
14. Retention in an antiretroviral therapy programme during an era of decreasing drug cost in Limbe, Cameroon. Mosoko JJ, Akam W, Weidle PJ, Brooks JT, Aweh AJ, Kinge TN, J Int AIDS Soc 2011 14 32 10.1186/1758-2652-14-32 21679416
15. World Health Organisation, Antiretroviral therapy for HIV infection in adults and adolescents.Recommendations for a public health approach: 2010 revision http://whqlibdoc.who.int/publications/2010/9789241599764-eng.pdf
16. Scaling up access to antiretroviral treatment for HIV infection: the impact of decentralization of healthcare delivery in Cameroon. Boyer S, Eboko F, Camara M, Abe C, Nguini ME, Koulla Shiro S, AIDS 2010 24 Suppl 1 5 15 10.1097/01.aids.0000366078.45451.46
17. Decentralization of HIV care in Cameroon: increased access to antiretroviral treatment and associated persistent barriers. Loubiere S, Boyer S, Protopopescu C, Bonono CR, Abega SC, Spire B, Health Policy 2009 92 2-3 165 73 19371960
18. Outcomes of antiretroviral treatment program in Ethiopia: retention of patients in care is a major challenge and varies across health facilities. Assefa Y, Kiflie A, Tesfaye D, Mariam DH, Kloos H, Edwin W, BMC Health Serv Res 2011 11 81 10.1186/1472-6963-11-81 21501509
19. Joint United Nations Programme on HIV/AIDS (UNAIDS) Global report, UNAIDS report on the global AIDS epidemic Geneva 2010
20. Correcting mortality for loss to follow-up: a nomogram applied to antiretroviral treatment programmes in sub-Saharan Africa. Egger M, Spycher BD, Sidle J, Weigel R, Geng EH, Fox MP, PLoS Med 2011 8 Suppl 1 1000390 21267057
21. Comparison of methods to correct survival estimates and survival regression analysis on a large HIV African cohort. Henriques J, Pujades-Rodriguez M, McGuire M, Szumilin E, Iwaz J, Etard JF, PLoS One 2012 7 Suppl 2 31706 22384061
22. Epidemiology of plasmodium-helminth co-infection in Africa: populations at risk, potential impact on anemia, and prospects for combining control. Brooker S, Akhwale W, Pullan R, Estambale B, Clarke SE, Snow RW, Am J Trop Med Hyg 2007 77 Suppl 6 88 98 18165479
23. Efavirenz versus nevirapine-based initial treatment of HIV infection: clinical and virological outcomes in Southern African adults. Nachega JB, Hislop M, Dowdy DW, Gallant JE, Chaisson RE, Regensberg L, AIDS 2008 22 Suppl 16 2117 25 18832875
24. Comparing the effectiveness of efavirenz and nevirapine for first-line antiretroviral treatment amongst an adult treatment cohort from South Africa. Bock P, Fatti G, Grimwood A, J Inter AIDS Soc 2010 13 Suppl 4 10
25. A review of the virological efficacy of the 4 World Health Organization-recommended tenofovir-containing regimens for initial HIV therapy. Tang MW, Kanki PJ, Shafer RW, Clin Infect Dis off publ Infect Dis Soc Am 2012 54 Suppl 6 862 75
26. World Health Organisation, Technical update on treatment optimization: use of efavirenz during pregnancy:a public health perspective 2012 http://whqlibdoc.who.int/publications/2012/9789241503792-eng.pdf
27. Daily co-trimoxazole prophylaxis in severely immunosuppressed HIV-infected adults in Africa started on combination antiretroviral therapy: an observational analysis of the DART cohort. Walker AS, Ford D, Gilks CF, Munderi P, Ssali F, Reid A, Lancet 2010 375 Suppl 9722 1278 1286 20347483
28. World Health Organisation: WHO Traditional Medicine Strategy 2002-2005. 2002. http://www.who.int/medicinedocs/en/d/Js2297e/.